Podcasts about consumer health

Dr. Jason Wersland turned a 3 a.m. garage experiment into the number one percussive therapy brand in the world, with more than 6.5 million Theragun massage devices sold. In this episode, he breaks down the unglamorous eight-year grind behind that overnight success: five prototypes, three bad partners, and a one-to-one credibility-building strategy that eventually landed him in Cristiano Ronaldo''s training room. For more on Therabody and show notes click here   Subscribe and watch Shopify Masters on YouTube!Sign up for your FREE Shopify Trial here.

Ray White speaks to Johan Gellatly, MD of Altron FinTech, about the latest Household Resilience Index and what it reveals about the fragile recovery in consumer finances, the impact of rising interest rates on spending and credit behaviour, and why merchants and lenders need to read these early warning signals to better manage risk and cash flow in an increasingly uncertain economic environment. The Money Show is a podcast hosted by well-known journalist and radio presenter, Stephen Grootes. He explores the latest economic trends, business developments, investment opportunities, and personal finance strategies. Each episode features engaging conversations with top newsmakers, industry experts, financial advisors, entrepreneurs, and politicians, offering you thought-provoking insights to navigate the ever-changing financial landscape.    Thank you for listening to a podcast from The Money Show Listen live Primedia+ weekdays from 18:00 and 20:00 (SA Time) to The Money Show with Stephen Grootes broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/7QpH0jY or find all the catch-up podcasts here https://buff.ly/PlhvUVe Subscribe to The Money Show Daily Newsletter and the Weekly Business Wrap here https://buff.ly/v5mfetc The Money Show is brought to you by Absa     Follow us on social media   702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/CapeTalk 702 on YouTube: https://www.youtube.com/@radio702   CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/Radio702 CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Charles Schwab's Kevin Gordon talks about the latest imports and exports data and what it means for consumer spending and GDP. He points out that real wage growth dipped into negative territory, a yellow flag for consumer health. On the jobs front, Kevin doesn't see a "full-fledged hiring boom" taking shape but doesn't see it as a bad thing for job seekers. He then turns to the small cap outperformance and what it means for the stock market. ======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

„Den Nordstern immer wieder neu aufzuhängen, ist überlebenswichtig.“ In dieser Episode spricht Franz Kubbillum mit Dr. Anja Kohnhäuser, Co-Founder und Geschäftsführerin von OMMAX, einem führenden europäischen Beratungshaus für Tech, Data und KI. OMMAX unterstützt mittelständische Unternehmen, Konzerne und Investoren dabei, auf Basis von Technologie, Daten und Künstlicher Intelligenz Wettbewerbs- und Zukunftsfähigkeit aufzubauen – von Digital-, Daten- und KI-Strategien über konkrete Implementierungen bis hin zu Commercial-, Tech- und AI-Due-Diligences. Mit dem Leitsatz „Building Digital Leaders“ arbeitet das Unternehmen seit zwölf Jahren daran, Kundenteams zu enablen, nachhaltige digitale Geschäftsmodelle zu entwickeln und sich als paneuropäische Plattform für Data, Tech und AI zu etablieren – flankiert durch den Wachstumspartner Eurazeo. Kohnhäuser schildert ihren Weg von der Promotion und ersten Karrierestationen hin zur Mitgründung von OMMAX und dem Aufbau eines mittlerweile rund 300-köpfigen Teams. Sie spricht über die Bedeutung eines klaren gemeinsamen Nordsterns im Gründerteam, den Aufbau eines belastbaren Private-Equity- und Unternehmensnetzwerks, das Zusammenspiel von Strategie- und Umsetzungsprojekten sowie ihre Rolle zwischen Kundengeschäft (u. a. Healthcare, Consumer Health, Digital Health, FMCG, Travel, Automotive), People & Culture und externer Repräsentanz. Zudem gibt sie Einblicke in ihre persönlichen Routinen – vom fokussierten Arbeitsweg auf dem Fahrrad über das „Anja-Audit“ als regelmäßige 360-Grad-Reflexion bis zur Organisation eines anspruchsvollen Alltags als Gründerin und Mutter. Diese Fragen werden in der Episode beantwortet: - Wie hat sich OMMAX von der universitätsnahen Vorfirma zu einem der führenden europäischen Player für Data-, Tech- und KI-Beratung mit klarer Vision und PE-Partner entwickelt? - Wie unterstützt OMMAX Unternehmen und Investoren ganzheitlich – von Digital- und KI-Strategie über konkrete Use Cases (z. B. in der Lebensmittelindustrie) bis zur langfristigen Enablement-Arbeit mit Kundenteams? - Welche Prinzipien, Netzwerktaktiken und persönlichen Routinen helfen Anja Kohnhäuser, in einem hochdynamischen Umfeld wirksam zu führen und zugleich ihren eigenen „Nordstern“ im Blick zu behalten? Themen: - C-level - Digital Transformations - Consulting - KI ----- Über Atreus – A Heidrick & Struggles Company Atreus garantiert die perfekte Interim-Ressource (m/w/d) für Missionen, die nur eine einzige Option erlauben: nachhaltigen Erfolg! Unser globales Netzwerk aus erfahrenen Managern auf Zeit zählt weltweit zu den besten. In engem Schulterschluss mit den Atreus Direktoren setzen unsere Interim Manager vor Ort Kräfte frei, die Ihr Unternehmen zukunftssicher auf das nächste Level katapultieren. ▶️ Besuchen Sie unsere Website: https://www.atreus.de/ ▶️ Interim Management: https://www.atreus.de/kompetenzen/service/interim-management/ ▶️ Für Interim Manager: https://www.atreus.de/interim-manager/ ▶️ LinkedIn-Profil von Dr. Anja Konhäuser: https://www.linkedin.com/in/dr-anja-konh%C3%A4user-28282297/ ▶️ Profil von Franz Kubbillum: https://www.atreus.de/team/franz-kubbillum/

Meredith Whitney, CEO at Meredith Whitney Advisory Group discusses the on-going market impact of the war in Iran, consumer health, the labor market and more. She speaks with hosts Tom Keene and Paul Sweeney.See omnystudio.com/listener for privacy information.

The Quest to Make Healthcare Preventive, Personalized & Retail-Like Join the celebration of reaching 500 episodes! Jared and Zain point to insights that have stood out as consumer-centric healthcare has evolved, and connect the dots for what's coming next, from how perceptions have shifted over the years, to how preventive health has moved from the margins to the middle, what role the health tech ecosystem is playing, and what it all means for everyday people engaging in their health.  All that, plus the Flava of the Week about the Movement of Consumer Health. What's driving the greatest momentum that we've ever seen in this space, and how are we influencing the industry to grow its adoption? Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this Daily Editorial, I sit down with Joel Elconin, co-host of the Pre-Market Prep Show and founder of the Stock Trader Network, to examine the current macroeconomic landscape, key corporate earnings, and sector-specific momentum. The Semiconductor and AI Phenomenon: A look into whether current semiconductor valuations mirror the dot-com bubble or if strong corporate cash flows justify the historic market run. Nvidia Earnings and Guidance Realities: Evaluating the market's high bar for Nvidia following its recent report and what the post-earnings price action signals for tech momentum. Consumer Health and Retail Barometers: Analyzing recent earnings from retail giants Walmart and Target to gauge consumer spending strength amid fluctuating energy costs. Inflation, the Fed, and Interest Rates: Discussing recent sticky inflation metrics, the potential impact of crude oil prices, and what a shifting political landscape could mean for future Federal Reserve policy. The Looming IPO Wave and Market Liquidity: Weighing whether highly anticipated public debuts could signal a cyclical market top and if enough capital liquidity exists to absorb them. Government Action in Quantum Computing: Examining the Trump administration's active involvement in the quantum sector and how investors should play government-backed tech trends. Precious Metals Technical Analysis: Breaking down the near-term technical correction in gold and silver charts against their long-term bullish structures. Stocks Mentioned: Micron Technology (NASDAQ: MU), Samsung (OTC: SSNLF), Nvidia (NASDAQ: NVDA), Walmart (NYSE: WMT), Target (NYSE: TGT), Intel (NASDAQ: INTC), IBM (NYSE: IBM).   Click here to visit Joel's PreMarket Prep website - https://www.premarketprep.com/   Click here to visit the Stock Trader Network - https://www.stocktradernetwork.com/   ----------------------- For more market commentary & interview summaries, subscribe to our Substacks:  The KE Report: https://kereport.substack.com/  Shad's resource market commentary: https://excelsiorprosperity.substack.com/ Investment Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any security or investment product. Investing in equities, commodities, really everything involves risk, including the possible loss of principal. Do your own research and consult a licensed financial advisor before making any investment decisions. Guests and hosts may own shares in companies mentioned.

Episode 218: In this episode of Accelerate Podcast, host Nicola Graham is joined by Dr Naomi Myhill — Director of Applied Science at Cascaid Health, a proactive health platform applying elite sport methodology to consumer health and longevity. ㅤ Before joining Cascaid Health, Naomi spent years working across elite women's football with both The FA and City Football Group, helping bridge the gap between research and practice. Her work focused on translating complex performance constructs into actionable metrics and interventions — giving coaches and practitioners clearer insights to support faster, better decision-making. ㅤ At the centre of the conversation is the challenge of applying elite sport principles outside of high-performance environments. Naomi shares why so much health data fails to create meaningful behaviour change, what it takes to build systems that genuinely move people forward, and how elite sport methodologies can shape the future of consumer health and longevity. ㅤ The discussion also explores the female athlete landscape — from data collection and interpretation, to the broader challenges and opportunities involved in building more individualised health and performance systems. ㅤ Topics Discussed: What Elite Sport Can Teach Consumer Health Why Most Health Data Fails to Change Behaviour Building Systems That Actually Move People Forward The Female Athlete and Data Translating Research Into Practice Health, Longevity and Behaviour Change - Where you can find Naomi: Website -  Sponsors Gameplan is a rehab Project Management & Data Analytics Platform that improves operational & communication efficiency during rehab. Gameplan provides a centralised tool for MDT's to work collaboratively inside a data rich environment VALD Performance, makers of the Nordbord, Forceframe, ForeDecks and HumanTrak. VALD Performance systems are built with the high-performance practitioner in mind, translating traditionally lab-based technologies into engaging, quick, easy-to-use tools for daily testing, monitoring and training Hytro: The world's leading Blood Flow Restriction (BFR) wearable, designed to accelerate recovery and maximise athletic potential using Hytro BFR for Professional Sport.  -  Where to Find Us Keep up to date with everything that is going on with the podcast by following Inform Performance on: Instagram Twitter Our Website - Our Team Andy McDonald Ben Ashworth Nicola Graham Steve Barrett  Pete McKnight

Haarausfall ist für viele ein emotionales Tabuthema – doch für Alessandro Causarano wurde es zum Startpunkt einer beeindruckenden Skalierungsgeschichte. In dieser Folge von How to Hack spricht Carsten Puschmann mit Alessandro Causarano, Co-Founder und Managing Director von O.C. Hairsystems. Alessandro berichtet, wie er vom Studenten über den Aufbau und Verkauf eines Premium-Fleisch-Business schließlich bei der Lösung für ein Problem landete, das 80 % aller Männer und 45% aller Frauen betrifft: schwindendes Haar. Von den ersten „Perücken-Bergen“ im Kinderzimmer seines Co-Founders während der Pandemie bis hin zu einem Unternehmen mit über 150 Mitarbeitenden – Alessandro erklärt, warum moderne Haarsysteme nichts mehr mit dem „Toupet-Image“ der 80er Jahre zu tun haben. Er gibt tiefe Einblicke in seine omnichannel Strategie aus digitaler Beratung und stationärem Retail, die Bedeutung von echtem Kundenvertrauen und warum er heute sowohl mit Banken als auch mit Venture Capital skaliert. Wir reden über:

The food you see on the supermarket shelves doesn't end up there by accident. It's often been rigorously tested for likeability. This week on Our Changing World, Liz Garton finds out about the science behind those decisions, given that individual taste can be very varied. Sign up to the Our Changing World monthly newsletter for episode backstories, science analysis and more.Learn more:Export markets are a key consumer group. Look at who's eating our food with this story from RNZ's Farah Hancock.Our Changing World looked at how science can help pair foods with the School of Chemical Science at the University of AucklandFinding a Psa-V-tolerant golden kiwifruit was one of the success stories from the Consumer and Health sciences team. Claire Concannon looked at the ongoing efforts to prevent the disease from getting to the South Island. Guests:Christina Roigard, Science Team Leader – Sensory & Consumer Health, New Zealand Institute for Bioeconomy Science LimitedDavid Jin, Scientist, Health and Consumer Science Team - New Zealand Institute for Bioeconomy Science LimitedDr Roger Harker, Principal scientist - Health and Consumer Science Team - New Zealand Institute for Bioeconomy Science LimitedGo to this episode on rnz.co.nz for more details

ViVE '26: Aegis Ventures' John Beadle on the Economics of Consumer Health Live from ViVE '26, John Beadle, Managing Partner and Co-Founder of Aegis Ventures, helps Jared understand the economics of consumer-driven health. Jon discusses the shift to consumer health through the eyes of an investor, where the money's going in 2026, and how several solutions in the Aegis portfolio are reframing what ""patient-centric"" really means.  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Molecule to Market, you'll go inside the outsourcing space of the global drug development sector with Alessandro Maselli, President and Chief Executive Officer at Catalent and Franco Negron is the Chief Executive Officer at Simtra BioPharma Solutions.   Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology ecosystem with his esteemed guests during a live fireside chat at the DCAT Morgan Stanley CDMO CEO Dinner.   Alessandro Maselli is the President and Chief Executive Officer of Catalent, having assumed the CEO role in July 2022 after serving as the company's President and Chief Operating Officer since February 2019.  He has been with Catalent since 2010 and has played a central role in shaping the company into one of the world's leading contract development and manufacturing organizations serving pharmaceutical, biotechnology, and consumer health customers globally.   Alessandro joined Catalent as Director of Operations at the company's pharmaceutical, nutrition, and cosmetics facility in Italy. Over the course of more than a decade, he progressed through a series of increasingly senior leadership roles, including General Manager of the Zydis® operations in Swindon, U.K., Vice President of Operations for Europe within the Drug Delivery Solutions business, and Senior Vice President of Global Operations. In these roles, he oversaw multi-site global manufacturing networks, large-scale capacity expansions, and complex technology platforms across oral solid dose, biologics, and advanced delivery modalities.   As Chief Executive Officer, Alessandro led Catalent through the COVID-19 pandemic, during which the company played a critical role in the global response by supporting vaccine and therapeutic manufacturing at unprecedented scale. More recently, he has overseen Catalent's transition to private ownership following its $16.5 billion acquisition by Novo Holdings, positioning the company for long-term investment and growth as a privately held global CDMO.   Prior to joining Catalent, Mr. Maselli held a range of operational and business leadership roles at ABB Group, Alstom, and SGS, gaining extensive experience in industrial automation, engineering, and large-scale manufacturing operations. He began his career as an automation systems engineer in the food industry. In addition to his executive role, Alessandro serves on the Board of Directors of Graphic Packaging Holding Company, to which he was appointed in May 2025. He holds bachelor's and master's degrees in electronic engineering from the University of Rome and is a native of Italy.   Franco Negron is the Chief Executive Officer of Simtra BioPharma Solutions, a leading sterile injectable contract development and manufacturing organization formed following the divestiture of Baxter International's BioPharma Solutions business. He was appointed CEO in 2023 by Advent International and Warburg Pincus to lead the business as an independent, private-equity-backed CDMO focused on clinical-to-commercial parenteral manufacturing. Franco is an industry veteran with nearly 30 years of pharmaceutical and biopharmaceutical experience, bringing deep expertise across sterile manufacturing, commercial operations, and global supply chain leadership. Prior to joining Simtra, he served as Chief Executive Officer of ApiJect Systems America, a medical technology company focused on advanced drug-delivery and injection systems. Earlier in his career, he held senior executive roles at Thermo Fisher Scientific, where he served as President of Commercial Operations, and at Patheon Pharmaceuticals, where he was President of Development and Commercial Operations, North America, playing a key role in scaling Patheon's CDMO platform prior to its $7.2 billion acquisition by Thermo Fisher in 2017.   Franco has also held leadership positions at several major pharmaceutical companies, including Vice President of Manufacturing and Supply at Valeant Pharmaceuticals, Global Vice President within Novartis' Consumer Health division, and Site General Manager at McNeil Consumer Healthcare.   Across these roles, he developed a reputation for operational excellence, customer-centric leadership, and the ability to lead complex manufacturing organizations through periods of transformation and growth. As CEO of Simtra, Franco is leading the company through its next phase of expansion, focused on strengthening its sterile fill-finish capabilities, advancing technical differentiation, and investing in capacity to support increasing demand for injectable biologics, vaccines, and complex parenteral products   Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We'd also appreciate a positive rating!

What does a potential energy shock mean for inflation, growth, and the Fed's next move? • Learn more at thriventfunds.com • Follow us on LinkedIn • Share feedback and questions with us at podcast@thriventfunds.com • Thrivent Distributors, LLC is a member of FINRA and a subsidiary of Thrivent, the marketing name for Thrivent Financial for Lutherans. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

The Quest To Make Consumer Health Apps Sticky Stephen Rouse shares the gap in the market that led him to found Savva AI, why screenings play such a large role in engagement, and what's possible when you unleash AI on your medical records.  All that, plus the Flava of the Week about Garmin's meal tracking feature. What can we learn from the way that meal tracking has evolved, and why is it now considered an essential feature of wellness apps?  Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/

In this episode of Disruption/Interruption, KJ sits down with Oleg Kovalev, Chief Marketing Officer at Aspect Health, revealing how his company became the #1 women's hormonal health startup in the USA by disrupting traditional PCOS treatment. Discover how continuous glucose monitoring and lifestyle coaching are helping one in five women manage a condition that doctors have been treating wrong for decades—and how this medical innovation is driving explosive business growth. Four Key Takeaways: [4:21] PCOS affects 20% of women and is the #1 cause of infertility - Traditional medicine has underdiagnosed and undertreated PCOS for decades, leaving millions of women without proper answers or solutions beyond pills that mask symptoms. [8:33] Managing glucose levels can dramatically reduce PCOS symptoms - Simple lifestyle changes combined with continuous glucose monitoring help women see real-time correlations between their food choices and symptom improvement, leading to exceptional product retention. [17:24] Data-driven positioning beats gut feeling every time - Aspect Health grew 12x in nine months by systematically testing positioning through paid ads and user behavior metrics rather than relying on intuition or assumptions. [24:11] Ask what you should NOT be doing - Focus and intentionality come from eliminating tasks rather than adding them—the critical question every founder and marketer must answer to achieve breakthrough success. Quote of the Show (8:00):"When women go to doctor and they ask questions about PCOS, in most cases they don't get answers to their questions. Often they are given some standard protocol of taking some kind of pills." - Oleg Kovalev Join our Anti-PR newsletter where we’re keeping a watchful and clever eye on PR trends, PR fails, and interesting news in tech so you don't have to. You're welcome. Want PR that actually matters? Get 30 minutes of expert advice in a fast-paced, zero-nonsense session from Karla Jo Helms, a veteran Crisis PR and Anti-PR Strategist who knows how to tell your story in the best possible light and get the exposure you need to disrupt your industry. Click here to book your call: https://info.jotopr.com/free-anti-pr-eval Ways to connect with Oleg Kovalev LinkedIn: https://www.linkedin.com/in/alecko/Company Website: www.aspect-health.com How to get more Disruption/Interruption: Amazon Music - https://music.amazon.com/podcasts/eccda84d-4d5b-4c52-ba54-7fd8af3cbe87/disruption-interruption Apple Podcast - https://podcasts.apple.com/us/podcast/disruption-interruption/id1581985755 Spotify - https://open.spotify.com/show/6yGSwcSp8J354awJkCmJlDSee omnystudio.com/listener for privacy information.

No 39º episódio do podcast Walking Meeting, Inês Simas do Departamento de Marketing conversou com Bruno Mestre Martins da Angelini Pharma sobre Fast Moving Consumer Health. O Bruno Mestre Martins iniciou o seu percurso no grande consumo e mais tarde, entrou na área da saúde. Atualmente trabalha na Angelini Pharma, onde é Global Consumer Health Commercial Operations Asociate Director. Nos escritórios do Departamento de Marketing em Oeiras conversámos sobre este conceito emergente, não académico, e que na verdade traduz uma evolução estratégica do setor. Falámos sobre a necessária mudança de mentalidades, de rapidez de reação e da necessidade de ter metodologias de criação e gestão de marcas. Evidentemente também falámos de regulação e ética e de como construir uma marca neste mundo onde há poucos cinzentos.  No final o Bruno contou-nos as características que procura num brand manager. Calce os ténis, se não chover, coloque os auriculares e venha connosco!

How Artists Helped Camouflage The MilitaryCamouflage wasn't just engineered. It was designed. From World War I “dazzle ships” to today's complex digital patterns, We trace how creative artists reshaped the look of warfare and changed the way the military thinks about perception, illusion and survival.Guest: Roy R. Behrens, artist, camouflage researcher.Host: Gary PriceProducer: Amirah Zaveri   When Family And Money CollideHelping an adult child can feel like love in action until it quietly turns into dependence. We speak with financial psychologist Blad Klontz to understand how financial support - even when rooted in good intentions - can blur boundaries, strain relationships and create a long-term cycle that's harder to break than most parents expect.  Guests: Brad Klontz, financial psychologist, co-author of Start Thinking Rich.Host: Marty PetersonProducer: Polly Hansen   Viewpoints Explained: The Showdown At The Federal ReserveWhen presidents clash with the Federal Reserve, it's more than political theater, but a test of how independent the nation's central bank really is. We examine why interest rates matter so much and what's at stake when politics collides with the levers of the larger U.S. economy.Host: Ebony McMorrisProducer: Amirah Zaveri   Culture Crash: The Internet's Favorite Song Isn't On StreamingA bonus track no one can officially stream has become one of the internet's most emotional anthems thanks to Tik Tok. We look at Twenty-One Pilots new hit single and why its drawn in millions.Host:  Evan Rook Producer: Evan Rook Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Viewpoints Explained: The Showdown At The Federal ReserveWhen presidents clash with the Federal Reserve, it's more than political theater, but a test of how independent the nation's central bank really is. We examine why interest rates matter so much and what's at stake when politics collides with the levers of the larger U.S. economy.Host: Ebony McMorrisProducer: Amirah Zaveri Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

About this episode: Products and services like genetic testing, prescriptions for weight loss drugs, and health monitoring wearables are revolutionizing health and wellness in the U.S. But are these new gadgets and offerings easing the challenges facing the health care system or are they exacerbating them? In this episode: Dr. Josh Sharfstein speaks with health care entrepreneur Ashwini Nagappan about the pros and cons of the explosion of direct-to-consumer health care. Guests: Ashwini Nagappan, PhD, is a health care entrepreneur and researcher. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: How direct-to-consumer health tests could impact insurance, mortgages, and employment—STAT More pharma giants embrace direct-to-consumer sales—Axios A sneak peek of pharma's Super Bowl ads: GLP-1s, tight ends, and more—STAT Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌PublicHealthPod on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

In this episode, Eric Malzone sits down with industry veteran and Harrison Co. partner Paul Byrne to unpack the "consumer health revolution" transforming fitness, healthcare, and longevity—from GLP‑1s and peptides to wearables, AI "robo docs," and accessible longevity clinics.​ ✨ Key takeaways

It's Episode 222 (“the triple deuces”), and the crew kicks things off from the brand-new EC Studios Greenville branch—then opens with a very public apology for the episode dropping late (yes, including the MLK Day mix-up). From there it's classic BLC riffing on wild headlines: PBR's Godzilla-themed 99-pack, fast-food weirdness (including a mayo variation being tested), and a story about “protein powder” that allegedly turned out to be cake batter—plus the consumer health implications. #blcpodcast #podcastingforthepeople #funny #podcast #greenvillesc #scpodcast #yeahthatgreenville Listen at: https://americasfavoritepodcast.com Tweet the Show: https://twitter.com/blcworld Follow us on Facebook: https://www.facebook.com/blcpodcast/ Check us out on Instagram: https://www.instagram.com/blcpodcast/ Buy Fred and Allan Beer: https://www.patreon.com/blcworld

For the 184th episode of the Healthcare IT Today Podcast, we are talking about how we think consumer health tech will impact provider organizations! We kick this episode off by sharing what consumer health tech has us most excited. Next, we talk about what consumer health tech we think won’t last. Then, we debate how we think the adoption of consumer health tech will impact provider organizations. Lastly, we end this episode by theorizing how long we think it will be until we have an AI doctor at our beck and call. Here's a preview of the topics and questions we discuss in this episode: What consumer health tech has you most excited? What consumer health tech do you think won't last? How will consumer health tech's adoption impact provider organizations? How long until we all have an AI doctor at our beck and call? Now, without further ado, we’re excited to share with you the next episode of the Healthcare IT Today podcast. We publish a new Healthcare IT Today podcast every ~2 weeks. Thanks to our friends at Healthcare Now Radio, you’ll be able to listen to the latest episodes of Healthcare IT Today on their radio station for the first two weeks. Then, we’ll be publishing each episode as a podcast and YouTube video here after it finishes on the radio. You can also subscribe to the Healthcare IT Today podcast on any of the following platforms: Apple Podcasts Google Podcasts Stitcher Podcast Radio TuneIn Spotify iHeartRadio Pandora Thanks for listening to Healthcare IT Today and if you enjoy the content we’re sharing, please rate the podcast on your favorite podcasting platform. Along with the popular podcasting platforms above, you can Subscribe to Healthcare IT Today on YouTube.  Plus, all of the audio and video versions will be made available to stream on HealthcareITToday.com. If you work in Healthcare IT, we’d love to hear where you agree and/or disagree with the perspectives we shared. Feel free to share your thoughts and perspectives in the comments of this post, in the YouTube comments, with @Colin_Hung or @techguy on Twitter, or privately on our Contact Us page. Let us know what you think of the podcast and if you have any ideas for future episodes. Thanks so much for listening! Listen to Our Latest Episodes:

Hosts Colin Hung and John Lynn discuss How Will Consumer Health Tech Impact Provider Organizations? To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

SomX's James Somauroo, Jess Somauroo, and Harry Salt dive into a week of big news from OpenAI with Dr Harvinder Power, Co-Founder and CEO at Motics.Join us to unpack ChatGPT Health. The good, the bad, and the ugly.00:00 - Intro01:32 - OpenAI Report: AI as a Healthcare Ally + ChatGPT Health

As we roll into the new year, The AG Show is diving into the latest trends shaping how health‑conscious consumers are eating. From the rise of high‑protein and high‑fibre everything, to the buzz around weight‑loss jabs and supplements, AHDB's consumer guru Vanessa Adamson and nutrition and health top bod Kate Arthur help us make sense of it all. They join Charlotte, Hannah and Tom to unpack what these shifts could mean for our plates -and our farmers.Plus, Farmer Tom is back! He's giving us an update on his Farmer Time charity and how it's reconnecting kids with the fields and farms where their food begins.SOME USEFUL BITSThe new consumer health revolution | AHDB2026 consumer health predictions | AHDBFarmer Time | Connecting Classrooms & FarmsGET IN TOUCHCharlotte, Hannah, and Tom would love to hear what you think! Got feedback, stories, or ideas for future episodes? Drop them a message at agshow@ahdb.org.uk.Sign up to the AHDB Preference Centre so that you can:Easily update your preferences and contact informationGet information on the latest AHDB events, webinars, market insights and moreReceive important updates such as disease alerts

Brent Dial, Founder and CEO of Beek Health, has built a platform that addresses patient information fragmentation by aggregating data from patient portals and providing direct access to lab testing. Health literacy is key to preventing chronic diseases, and AI is being used to scale the delivery of personalized health information. Identifying relevant biomarkers and early warning signs supports proactive health management that can alter long-term health outcomes. Brent explains, "Beek Health is re-imagining healthcare by finally putting the individual at the center of their health journey. While we talk about patient-centric or customer-centric or shared decision-making, it's not real in practice, and it's for good and for very clear reasons. There's information asymmetry, there's information overload, and then information is quite fragmented." "Currently, we have three subscription tiers. The first option is the basic plan, which gives you platform access to synthesize and connect with multiple patient portals, as many as you have. The average individual has at least two patient portals, and it's estimated you'll see 17 different providers in your lifetime. So that's a lot of data spread out across different systems. So, one, you can sync. We have over 40,000 endpoints or provider locations where you can sync your patient portal information in one unified dashboard. All the dashboards look different."  "Second, you'll have access to labs anytime you need them. And so labs are woefully underutilized for health tracking: 70% of diagnoses are based on lab results, so you can access them anytime you need to. We partner with LabCorp, which has over 2,000 locations, and you'll receive your results within 48 hours. In addition, we're adding cost navigation, cost estimate tools, and some more fun features on our roadmap, but that just gives you basic access for a year for $99."   #BeekHealth #HealthInYourHands #OwnYourHealthData #HealthTech #DigitalHealth #PatientEmpowerment #HealthcareReimagined #ConnectedHealth #FutureOfHealth beekhealth.com Listen to the podcast here

Brent Dial, Founder and CEO of Beek Health, has built a platform that addresses patient information fragmentation by aggregating data from patient portals and providing direct access to lab testing. Health literacy is key to preventing chronic diseases, and AI is being used to scale the delivery of personalized health information. Identifying relevant biomarkers and early warning signs supports proactive health management that can alter long-term health outcomes. Brent explains, "Beek Health is re-imagining healthcare by finally putting the individual at the center of their health journey. While we talk about patient-centric or customer-centric or shared decision-making, it's not real in practice, and it's for good and for very clear reasons. There's information asymmetry, there's information overload, and then information is quite fragmented." "Currently, we have three subscription tiers. The first option is the basic plan, which gives you platform access to synthesize and connect with multiple patient portals, as many as you have. The average individual has at least two patient portals, and it's estimated you'll see 17 different providers in your lifetime. So that's a lot of data spread out across different systems. So, one, you can sync. We have over 40,000 endpoints or provider locations where you can sync your patient portal information in one unified dashboard. All the dashboards look different."  "Second, you'll have access to labs anytime you need them. And so labs are woefully underutilized for health tracking: 70% of diagnoses are based on lab results, so you can access them anytime you need to. We partner with LabCorp, which has over 2,000 locations, and you'll receive your results within 48 hours. In addition, we're adding cost navigation, cost estimate tools, and some more fun features on our roadmap, but that just gives you basic access for a year for $99."   #BeekHealth #HealthInYourHands #OwnYourHealthData #HealthTech #DigitalHealth #PatientEmpowerment #HealthcareReimagined #ConnectedHealth #FutureOfHealth beekhealth.com Download the transcript here

From domestic and global policy to the speed of innovation, the American Seed Trade Association (ASTA) works on behalf of the industry to promote research, development and movement of quality seed to meet the world's demand for food, feed, fiber and beyond. This week, Beck's Hybrids' President, Scott Beck, hosts ASTA CEO, Andy LaVigne, and organization Chair, Dave Treinen, to talk about the organization's pursuit to better connect innovation to consumers, new markets, policymakers and more. We get into:   ASTA as one of the world's oldest trade organizations and who they aim to serve Where seed production finds itself in the mix of current challenges facing production agriculture and what is unique to them The biggest regulatory discussions shaping the industry, both domestically and internationally How domestic policy impacts the industry's ability to do business internationally The accelerated trend of food is health, the seed innovator's role and how ASTA is tackling this with its partners across the value chain How ASTA works to connect seed innovation to the consumer's understanding of food production Where ASTA sees the biggest opportunities to advance technologies through partnerships and collaborations Big areas of focus for 2026 The call to action for seed distributors and innovators that want a seat at the table with ASTA, but don't know how to get started 

En la edición de hoy del Radar Empresarial, la atención se centra en una sola protagonista: Johnson & Johnson. La compañía ha alcanzado una capitalización bursátil cercana a los 500.000 millones de dólares, culminando uno de los periodos más favorables de su historia reciente. Sus acciones acumulan una subida del 42% en lo que va de año, y noviembre no ha hecho más que reforzar esta tendencia positiva. La empresa encadena 13 sesiones consecutivas al alza, la racha más prolongada de su trayectoria, y solo en este mes sus títulos avanzan un 9,9%, un ritmo que no se veía desde 2020. Detrás de este impulso se encuentra, en gran medida, su intensa estrategia de adquisiciones. A comienzos de año, Johnson & Johnson cerró un acuerdo para comprar Intra-Cellular Therapies, fabricante especializado en tratamientos neurológicos, en una operación valorada en más de 14.000 millones de dólares, la cuarta compra más relevante en su historia. Con este movimiento, la empresa buscaba reforzar su división de fármacos y dispositivos médicos tras la separación, en 2023, de su negocio de Consumer Health. Esta escisión dio origen a la empresa independiente Kenvue, que también ha sido noticia recientemente después de que Kimberly-Clark haya pactado su adquisición por casi 50.000 millones de dólares. Esta desinversión permite a Johnson & Johnson no solo obtener una cantidad significativa de recursos, sino también consolidar la estrategia que tan buenos resultados le está proporcionando: concentrarse en la farmacéutica avanzada y las tecnologías médicas. En esa misma línea, este mes anunció la compra de Halda Therapeutics, un laboratorio centrado en terapias contra tumores sólidos, lo que refuerza su catálogo oncológico y abre nuevas oportunidades de crecimiento para los próximos años. Las previsiones internas de la compañía sugieren que el impulso continuará. Johnson & Johnson estima un aumento operativo de las ventas de entre el 4,8% y el 5,3% en 2025, y anticipa que en 2026 los ingresos crecerán por encima del 5%. Además, destaca por su rápida alineación con la nueva administración estadounidense, al anunciar un plan de inversiones de 50.000 millones de dólares en Estados Unidos para los próximos cuatro años.

The CPG Guys are joined in this episode by Zach Dennett, VP Merchandising for Consumer Health and Wellness, and Supplemental Benefits at CVS Pharmacy, the Front-Of-Store Retail Business Unit of CVS Health. Follow Zach on LinkedIn at: https://www.linkedin.com/in/zacharydennett/ Follow CVS Health online at: http://cvshealth.comFollow CVS Health on LinkedIn at: https://www.linkedin.com/company/cvshealth/Zach answers these questions:Since stepping into your current role in March 2024, what has been your primary focus within Consumer Health & Wellness front of store merchandising at CVS Health?CVS emphasizes seamless omnichannel experiences. What are key milestones in merging in-store and digital merchandising? With around 60 million digitally engaged customers, what are the biggest learnings about how digital influences in-store purchases in your category?What qualities do you look for in emerging brands seeking merchandising partnerships with CVS Health?CVS stores have shoppers coming for Rx, for OTC and even primary healthcare needs. How do you work with the other business owners within CVS Health to ensure your shoppers get the care that they need and how do brands play a role in this process?Could you share how your merchandisers interact with CVS Media Exchange to ensure that brands connect with your consumers in the path to purchase?What role does behavioral insights via loyalty data (e.g., ExtraCare insights) play in determining your merchandising strategies? In other statements, you've noted younger generations trust influencers over experts. How does this affect product merchandising strategy? How do you see CVS's merchandising role evolving over the next 3–5 years amid innovations like “instant commerce”?CPG Guys Website: http://CPGguys.comFMCG Guys Website: http://FMCGguys.comRhea Raj's Website: http://rhearaj.comLara Raj in Katseye: https://www.katseye.world/DISCLAIMER: The content in this podcast episode is provided for general informational purposes only. By listening to our episode, you understand that no information contained in this episode should be construed as advice from CPGGUYS, LLC or the individual author, hosts, or guests, nor is it intended to be a substitute for research on any subject matter. Reference to any specific product or entity does not constitute an endorsement or recommendation by CPGGUYS, LLC. The views expressed by guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent. CPGGUYS LLC expressly disclaims any and all liability or responsibility for any direct, indirect, incidental, special, consequential or other damages arising out of any individual's use of, reference to, or inability to use this podcast or the information we presented in this podcast.

Celebrating Europe's Consumer Health Best Practice, With AESGP's Luis Rhodes Baiao The Association of the European Self-Care Industry, or AESGP, has launched a digital platform that brings together inspiring self-care initiatives from across Europe. Launched to coincide with International Self-Care Day 2025, AESGP's Self-Care Insight and Inspire platform showcases national-level initiatives led or supported by the consumer health industry in collaboration with healthcare professionals, sectoral associations, and public authorities. In this episode of the Over the Counter podcast, AESGP governmental and public affairs manager, Luis Rhodes Baiao, tells HBW Insight about the background behind the platform and pulls out some of his favourite examples. Timestamps 2:00 – Introductions 5:15 – AESGP's Self-Care Insight and Inspire platform 14:30 – Luis's favourite examples 17:30 – Public reaction to the campaign 18:50 – Next steps 20:30 – How to get involved Guest Bio Luis Rhodes Baiao is governmental and public affairs Manager at AESGP. Before, he was policy advisor to a Portuguese Member of the European Parliament on the Committee for Environment, Public Health and Food Safety (ENVI), during the mandate 2014 to 2019. He is currently also vice-president of the General Assembly of the Association Public Affairs Portugal (PAPT).

Alliance for Natural Health sues FDA to allow truthful, science-based health claims for 118 vitamins, minerals and nutraceuticals in 1st Amendment test; What to do for H. pylori—or should it even be treated? Whole body MRI for cancer screening—is it worth undertaking? A remarkable new functional food supplement and beverage, harnessing the unique benefits of the muscadine grape. 

Kayla Brunn breaks down the Consumer Health Index, designed to track consumer demand “in real time.” Based on sentiment and unemployment data her firm gathers, they have created a tool to help investors get insight into consumer behavior and predict trends. Kayla explains how she thinks the index can be used and what it is helpful for.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

S&P 500 closed at a record high today. Our Kristina Partsinevelos tracks key stock movers, while Rick Santelli breaks down action in the bond market. Scott Wren of Wells Fargo and Adam Crisafulli of Vital Knowledge weigh in on where the second half of the year could be headed. Big Technology's Alex Kantrowitz reacts to Microsoft's plan to cut 9,000 jobs and what is says about broader tech labor landscape. Affirm CEO Max Levchin joins to discuss what he's seeing from consumers and payment trends Tim Seymour makes the case for getting bullish on health care.

The USDA estimates that between 30-40% of the US food supply is wasted every year – that's over 133 BILLION pounds. One farmer, turned soldier, turned entrepreneur is tackling that market. Ben Moore, founder of The Ugly Company, joins us to talk to fruit. We get into: Ben's connection to Indiana and how a farmer went on to create a trucking company that became The Ugly Company as it is today How damaged fruit with scars or other cosmetic issues because big business for Ben – The Ugly Company can now be found on store shelves of Target, Sam's Club, Walmart and Whole Foods The Ugly Company's goal to prevent food waste, where they are at in that target and how they hope to accelerate that goal in the future How the fruit becomes the product on shelves – The Ugly Process, if you will Ben's advice for aspiring farmers, business owners and entrepreneurs and lessons he's learned from leading his business and his time serving in the US Army What service looks like to him versus what it maybe looked like as a 22-year-old soldier What's ahead for The Ugly Company – including further distribution and availability in schools

The USDA estimates that between 30-40% of the US food supply is wasted every year – that's over 133 BILLION pounds. One farmer, turned soldier, turned entrepreneur is tackling that market. Ben Moore, founder of The Ugly Company, joins us to talk to fruit. We get into:  Ben's connection to Indiana and how a farmer went on to create a trucking company that became The Ugly Company as it is today How damaged fruit with scars or other cosmetic issues because big business for Ben – The Ugly Company can now be found on store shelves of Target, Sam's Club, Walmart and Whole Foods The Ugly Company's goal to prevent food waste, where they are at in that target and how they hope to accelerate that goal in the future How the fruit becomes the product on shelves – The Ugly Process, if you will Ben's advice for aspiring farmers, business owners and entrepreneurs and lessons he's learned from leading his business and his time serving in the US Army What service looks like to him versus what it maybe looked like as a 22-year-old soldier What's ahead for The Ugly Company – including further distribution and availability in schools 

While few doubt the opportunity represented by real-world evidence, some concerns remain about its validity compared to traditional forms of clinical evidence, particularly among regulators. To address these concerns, IQVIA Consumer Health's vice president of global research and development and real-world evidence services, Volker Spitzer, suggests that incorporating some elements of traditional trials, such as randomization, is a good way to persuade regulators that RWE can be used for consumer health innovation, for example in generating new claims or supporting Rx-to-OTC switch. Looking forward, Spitzer is excited about the ways in which digital health tools and artificial intelligence can be used to expand the scope of RWE as well as drive personalization for consumers. Timestamps: 3:00 - Addressing concerns about RWE's scientific rigour and validity 12:00 – Regulators' views of RWE, particularly for consumer health 16:00 – Use of RWE for Rx-to-OTC switch 22:00 – The future of RWE Guest Bio: Volker Spitzer has more than 30 years of R&D experience spanning the consumer health sector, ingredients industry, and academia. Beginning his career as a professor in pharmaceutical sciences, he ascended to global positions encompassing R&D, innovation, licensing/M&A, and medical marketing at firms like Roche, DSM Nutritional Products, and Bayer. Since October 2017, Spitzer has been affiliated with IQVIA Consumer Health, serving as the vice president for global R&D and RWE Services. His purview primarily includes clinical research, RWE, virtual trials, and the burgeoning field of digital health. He has penned over 80 scientific publications, whitepapers and textbooks centered on science and innovation.

Michael Linford, Chief Operating Officer at Affirm, breaks down the 'buy now, pay later' giant's recent earnings report, which pointed to lower-than-expected guidance going forward. While guidance did miss estimates, Linford explains that consumer health and spending are still solid despite negative sentiment from the global trade war. Linford also talks about how Affirm is navigating a consumer environment that is fearful of a potential recession.The content of the video is for general and informational purposes only. All views presented in this show reflect the opinions of the guest and the host. You should not take a mention of any asset, be it cryptocurrency or a publicly traded security as a recommendation to buy, sell or hold that cryptocurrency or security. Guests and hosts are not affiliated with or endorsed by Public Holdings or its subsidiaries. You should make your own financial and investment decisions or consult respective professionals. Full disclosures are in the channel description. Learn more at Public.com/disclosures.Past performance is not a guarantee of future results. There is a possibility of loss with any investment. Historical or hypothetical performance results, if mentioned, are presented for illustrative purposes only. Do not infer or assume that any securities, sectors or markets described in the videos were or will be profitable. Any statements of future expectations and other forward-looking statements are strictly based on the current views, opinion, or assumptions of the person presenting them, and should not be taken as an indicator of performance nor should be relied upon as an investment advice.

Exerting maximum influence on stakeholders, helping companies navigate regulatory complexity and promoting industry best practice are three big jobs that the UK consumer healthcare industry association, PAGB, has set itself for the next five years. In the last five years, PAGB has made significant headway with UK government, reports PAGB CEO Michelle Riddalls, establishing the economic and social value of self-care and ensuring that self-care is part of the UK's national healthcare strategy. Rx-to-OTC switch has been a major area of success, Michelle notes in this episode of the Over the Counter podcast. The Department of Health and Social Care recently published a list of switches it would like to see applications for, and PAGB is now facilitating members to take advantage of this opportunity. But there's always more work to be done. Switch involves significant risk, which PAGB is trying to reduce through further work with policy makers, and with a new government, the association must ensure that self-care remains high up on the agenda for politicians. Given the breadth of PAGB's work discussed by Michelle, we have split this episode into two, so watch out for the second part in two weeks' time on your favourite podcast provider and on Citeline's HBW Insight. Timestamps 2:10 – Introductions 2:40 – PAGB's new five-year strategy 5:40 – Evolution not revolution 8:00 – Self-care and UK government policy 10:30 – Quantifying the value of self-care 12:30 – Lobbying around AMR and OTCs 16:00 – Rx-to-OTC switch in the UK 24:00 – The power of brands Guest Bio Michelle Riddalls OBE is Chief Executive Officer of PAGB, the consumer healthcare association, which represents the manufacturers of branded over-the-counter (OTC) medicines, self-care medical devices and food supplements in the UK. Prior to joining PAGB, Michelle was Director of Regulatory Affairs for the Northern European Cluster at Pfizer Consumer Healthcare, where she was integral in the highly successful POM to GSL reclassification of Nexium Control and the Viagra Connect POM to P switch. Michelle has been recognised across a number of industry awards, including the Women in Trade Powerlist in 2024, and was awarded an OBE for outstanding services to consumer health in the King's 2025 New Year Honours.

The consumer healthcare industry is changing. Companies are separating from their pharmaceutical parents and brands are shifting from therapeutic solutions to preventative health and wellness options. These shifts bring a number of challenges for OTC firms, notes AdverCheck managing director James Walmsley in the second part of his chat with HBW. For example, it is much more difficult to get science-backed claims for food supplements approved, he points out. With firms now also becoming standalone consumer health entities, there is no longer a direct pipeline of off-patent prescription medicines available for Rx-to-OTC switch, he observes. We may, therefore, see a new generation of switch-focused self-care companies and partnerships emerging. Keywords: Innovation, AdverCheck, OTC medicines, Consumer Health, Rx-to-OTC switch Timeline

Brian Joyce charts U.S. rents and talks housing inflation. He shows technical trends he's watching on the homebuilders ITB ETF, and contrasts consumer staples and discretionary to look for warning signals.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – / schwabnetworkFollow us on Facebook – / schwabnetworkFollow us on LinkedIn - / schwab-networkAbout Schwab Network - https://schwabnetwork.com/about

Creativity can sometimes be about discovering what in retrospect seems obvious, like shoes that are shaped to fit our feet, marketing expert Beverley Law tells HBW Insight in the first episode of this season's Over the Counter podcast. But this often requires stepping out of established approaches and patterns of thinking, she points out, which tend to characterise innovation in the consumer health industry. Law offers some tips to help firms think outside the box, including being brave, benchmarking against the fast-moving consumer goods industry, and including regulatory experts much earlier on in the process.

 Every year brings new innovations and change in the health, wellness, and fitness industry…   As a coach or practitioner, it's important to know what the popular trends are even if you don't agree with them, since this will be on the minds of your current and future clients.   So on today's Integrative #HealthCoachSuccess episode 370 we'll be covering the “2025 Top Trends in Consumer Health & Wellness” - Enjoy the show and let us know what you think in the comments!   - - -   Listen or Watch At:  IHP.Coach/370   - - - Dr. Cabral's Book, The Rain Barrel Effect: https://amzn.to/2H0W7Ge - - - Become an Integrative Health Practitioner: https://integrativehealthpractitioner.org  

What is quality investing and how does it affect client portfolios? • Learn more at thriventfunds.com • Follow us on LinkedIn • Share feedback and questions with us at podcast@thriventfunds.com • Thrivent Distributors, LLC is a member of FINRA and a subsidiary of Thrivent, the marketing name for Thrivent Financial for Lutherans.

In this compelling episode of BRAVE COMMERCE, co-hosts Rachel Tipograph and Sarah Hofstetter sit down with Katie Williams, Chief Marketing Officer of Haleon. As a seasoned leader in consumer packaged goods (CPG), Katie shares her unique journey, navigating two major corporate spin-offs—Kraft-Mondelez and GSK-Haleon. She delves into the critical lessons learned about purpose-driven business strategies, brand identity, and leading through transformation in highly dynamic industries.Katie discusses Haleon's bold mission to redefine consumer health through trusted science and meaningful consumer connections. From developing a clear North Star to ensuring seamless brand transitions, she reveals how purpose anchors Haleon's decisions and fosters resilience amid change. Katie also highlights the growing importance of addressing consumer health holistically, blending physical and mental well-being, and adapting to the influence of digital platforms and creators in shaping health narratives.The conversation culminates with insights into Katie's leadership philosophy, emphasizing inclusivity and courage in decision-making. Whether addressing the power of brands or collaborating with retail partners on integrated media strategies, Katie's approach underscores the value of agility, authenticity, and innovation in today's fast-evolving commerce landscape.Key Takeaways:Purpose as a Compass: Establishing a clear mission helps organizations make cohesive decisions and maintain focus during transformative periods.Adapting to Evolving Consumer Needs: Integrating holistic health solutions and leveraging digital and social platforms are crucial for connecting with modern consumers.Unified Teams for Agility: Bringing together media, shopper marketing, and consumer experience teams fosters quick, aligned responses to retail and market shifts. Hosted on Acast. See acast.com/privacy for more information.

Stocks closed out a down week with declines across the major averages on Friday, led to the downside by tech. Morgan Stanley Global Head of Thematic and Macro Investing Ellen Zentner on what she is telling clients and RBC's Lori Calvasina on what you need to know for the weeks ahead. Netflix is airing Jake Paul vs. Mike Tyson and promotor of the fight, Nakisa Bidarian, discusses what the event means for Netflix, Paul and the future of streaming sports. Jefferies' Sheila Kahyaoglu on why defense stocks got hit this week—and what Elon Musk might have to do with it. Plus, FICO CEO William Lansing on the stock's rip higher and how the consumer looks from his vantage point. 

It's been nearly twenty years since 23andMe, the consumer health company was founded. Since then, other companies have emerged, and in exchange for a tube of spit, a puff of breath, or a drop of blood, consumers can now not only find their ancestry and long-lost relatives, but learn what to eat that day or discover food sensitivities and propensity for diseases. But are these tests effective and what are the pitfalls of using a company you found on Instagram to test whether you're likely to suffer from Alzheimer's or cancer? And when those companies cease to exist, as troubled 23andMe might, what happens to all that health data? It's one thing to share your email address or mobile number, and an entirely different proposition to share your genome. We'll talk to experts about the world of consumer DNA-testing and how to protect yourself and your genome. Guests: Kristen V. Brown, staff writer, Atlantic Magazine Hank Greely, law professor; founding director, Center for Law and the Biosciences, Stanford University

In this episode, Vijay Pande and Daisy Wolf of a16z Bio + Health join a16z Podcast host Steph Smith to make a provocative case for why technologists—not just medical professionals—are key to reinventing healthcare. They argue that to transform a sector representing 20% of U.S. GDP, innovation must move beyond curing diseases toward tackling healthcare's broken systems. By likening the healthcare industry to a logistics challenge, Vijay and Daisy outline how technologists can leverage their expertise in consumer engagement, operational efficiency, and AI to drive the next frontier of health innovation. They also explore high-impact opportunities like improving patient experiences and deploying AI for behavioral change at scale. If you're ready to explore new paths in healthcare, this episode is essential listening for understanding the powerful role technologists can play in shaping its future.

In this episode, Dr. Laura Sicola interviews Misty Davis, the Chief Marketing Officer of Circana. They discuss the importance of authenticity in communication, the value of understanding different personality types, and the power of going to bat for others. Misty shares her experiences of taking risks, delivering hard news, and finding humor in everyday situations. The conversation highlights the significance of acknowledging and celebrating the achievements of others. In this episode you will learn: Authenticity is key in effective communication. Understanding different personality types can improve communication and collaboration. Taking risks can lead to personal and professional growth. Delivering hard news requires finesse and empathy. Finding humor in everyday situations can lighten the mood and humanize conversations. Acknowledging and celebrating the achievements of others is important for building a positive and supportive work environment. About Misty Davis As Chief Marketing Officer at Circana, Misty Davis drives multiple marketing and sales initiatives to align with the company's growth strategies, with the goal of accelerating demand, awareness, and ecosystem growth. She leads the continuous evolution of corporate messaging, positioning, and execution of the company's narrative in key marketing assets, including digital presentations, campaigns, events, demos, sales enablement, and strategic communications. Davis is laser-focused on pipeline generation, ensuring the company communicates the right message at the right time and in the right place to all target audiences. She supports the company's brand to employees and the community, as well as manages internal communications and industry relations efforts. Previously, Davis had a 16-plus year career at Google, where she held several positions, the most recent of which was Director, Global Client and Agency Solutions, Consumer Packaged Goods, Consumer Health, and Tech. She began her career at Google working across U.S. teams, then in various markets throughout APAC in 2011, which catapulted her into the previous decade of global leadership opportunities. She is a thought leader and trusted confidant to her colleagues and a well-respected consultant with expertise in her field with clients.   You can connect with Misty in the following ways: LinkedIn: https://www.linkedin.com/in/mistymuscatel/ Circana website: https://www.circana.com/   You can connect with Dr. Laura Sicola in the following ways: LinkedIn: https://www.linkedin.com/in/drlaurasicola LinkedIn Business Page: https://www.linkedin.com/company/laurasicola-inc YouTube: https://www.youtube.com/@LauraSicolainc Facebook: Dr. Laura Sicola Twitter: @LauraSicola Instagram: @drlaurasicola Website: https://laurasicola.com Laura's Online Course: virtualinfluence.today See omnystudio.com/listener for privacy information.See omnystudio.com/listener for privacy information.

In this special combined episode of the Becker’s Healthcare and Private Equity Podcast, Scott Becker sits down with Alyssa Jaffee, Partner at 7wire Ventures. Alyssa shares insights into digital health investing, the evolution of healthcare during the pandemic, and the importance of consumer empowerment.